CHEK2 Founder Variants and Thyroid Cancer Risk.

Autor: Brock P; Division of Human Genetics, The Ohio State University College of Medicine, Comprehensive Cancer Center, Columbus, Ohio, USA., Liynarachchi S; Department of Molecular Medicine and Therapeutics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Nieminen TT; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Chan C; Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA., Kohlmann W; University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA., Stout LA; Indiana University School of Medicine, Indianapolis, Indiana, USA., Yao S; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., La Greca A; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado, USA., Jensen KE; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Kolesar JM; College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA., Salhia B; Department of Translational Genomics, Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, California, USA., Gulhati P; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Hicks JK; Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA., Ringel MD; Department of Molecular Medicine and Therapeutics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.

Publikováno v: Thyroid : official journal of the American Thyroid Association [Thyroid] 2024 Apr; Vol. 34 (4), pp. 477-483. Date of Electronic Publication: 2024 Feb 27.

Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.

Autor: Yap TA; University of Texas MD Anderson Cancer Center, Houston, TX., Stadler ZK; Memorial Sloan Kettering Cancer Center, New York, NY., Stout LA; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN., Schneider BP; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN.

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2023 Jun; Vol. 43, pp. e390738.

Identification of germline cancer predisposition variants during clinical ctDNA testing.

Autor: Stout LA; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA.; Indiana University Health Precision Genomics, Indianapolis, IN, USA., Kassem N; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA.; Indiana University Health Precision Genomics, Indianapolis, IN, USA., Hunter C; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA.; Indiana University Health Precision Genomics, Indianapolis, IN, USA., Philips S; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA., Radovich M; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA.; Indiana University Health Precision Genomics, Indianapolis, IN, USA., Schneider BP; Indiana University School of Medicine, 1030 W. Michigan St., Suite 3307, Indianapolis, IN, 46202, USA. bpschnei@iu.edu.; Indiana University Health Precision Genomics, Indianapolis, IN, USA. bpschnei@iu.edu.

Publikováno v: Scientific reports [Sci Rep] 2021 Jul 01; Vol. 11 (1), pp. 13624. Date of Electronic Publication: 2021 Jul 01.

Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy.

Autor: Schneider BP; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Stout LA; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Philips S; Indiana University School of Medicine, Indianapolis, IN., Schroeder C; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Scott SF; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Hunter C; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Kassem N; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Kiel PJ; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN., Radovich M; Indiana University School of Medicine, Indianapolis, IN.; Indiana University Health Precision Genomics, Indianapolis, IN.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 1109-1121.

Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC.

Autor: Tosello, Valeria¹ (AUTHOR), Grassi, Angela² (AUTHOR), Rose, Dominic³ (AUTHOR), Bao, Loc Carlo^4,5 (AUTHOR), Zulato, Elisabetta¹ (AUTHOR), Dalle Fratte, Chiara¹ (AUTHOR), Polano, Maurizio⁶ (AUTHOR), Del Bianco, Paola² (AUTHOR), Pasello, Giulia^4,5 (AUTHOR), Guarneri, Valentina^4,5 (AUTHOR), Indraccolo, Stefano^1,4 (AUTHOR) stefano.indraccolo@iov.veneto.it, Bonanno, Laura^4,5 (AUTHOR)

Publikováno v: Scientific Reports. 8/9/2024, Vol. 14 Issue 1, p1-12. 12p.